Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar plus Gemcitabine and Docetaxel in Soft Tissue Sarcoma
NCT01812018Phase 2Unknown
- Start
- Nov 2012
- Primary completion
- Apr 2015
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in soft tissue sarcoma (STS). Status: unknown.
02
Drugs
endostar
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01812018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01812018.